CAXTON CORP
Follow13F filer, CIK 1388551, Princeton, NJ
CAXTON CORP reported $2,783,915 across 13 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 96.36% of the portfolio.
Accepted , ingested 13F-HR 0000919574-26-007854
Changes against Q2 2026 are not shown: its report omitted holdings under a confidential treatment request (10 positions on file), so every position would read as new.
The filing omits holdings under a confidential treatment request (H8). A later amendment may add them.
- Period
- 2026-09-30
- Reported value
- $2.78M
- Holdings
- 13
- Top 10 weight
- 96.36%
- New
- Sold out
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0000919574-26-007854, largest first. % of portfolio is the value over $2,783,915, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| SPCXSPACE EXPLORATION TECHN CORP | 3,699 | $558K | 20.04% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| NFEGPNEW FORTRESS ENERGY INC | 1,214 | $486K | 17.44% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| BRK-BBERKSHIRE HATHAWAY INC DEL | 839 | $418K | 15% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| TSLATESLA INC | 829 | $294K | 10.57% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| VOOVANGUARD INDEX FDS | 378 | $265K | 9.51% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| GOOGLALPHABET INC | 769 | $265K | 9.5% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| BXBLACKSTONE INC | 1,780 | $200K | 7.17% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| KYTXKYVERNA THERAPEUTICS INC | 12,347 | $84K | 3.02% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| LXEOLEXEO THERAPEUTICS INC | 16,962 | $57.3K | 2.06% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| IKTINHIBIKASE THERAPEUTICS INC | 27,775 | $57.1K | 2.05% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| XFORX4 PHARMACEUTICALS INC | 13,534 | $39.2K | 1.41% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| SABSSAB BIOTHERAPEUTICS INC | 10,372 | $32.9K | 1.18% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| ALXOALX ONCOLOGY HLDGS INC | 20,946 | $29.1K | 1.05% | The filing omitted confidential holdings, a later amendment may add them. | Timeline |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000919574-26-007854 | base | 2026-11-16 |